Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based study-Reference-Cited by-同舟云学术

Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based study

Published:2019-05 Issue:5 Volume:6 Page:e276-e284
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Kizilors Aytug,Crisà Elena,Lea Nicholas,Passera Roberto,Mian Syed,Anwar Jamal,Best Steve,Nicolini Franck E,Ireland Robin,Aldouri Maadh,Pocock Christopher,Corbett Tim,Gale Richard,Bart-Smith Emily,Weston-Smith Simon,Wykes Clare,Kulasekararaj Austin,Jackson Sophie,Harrington Patrick,McLornan Donal,Raj Kavita,Pagliuca Antonio,Mufti Ghulam J,de Lavallade Hugues

Publisher

Elsevier BV

Subject

Hematology

Reference26 articles.

1. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013;Baccarani;Blood,2013

2. BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet;Soverini;Blood,2011

3. Finding of kinase domain mutations in patients with chronic phase chronic myeloid leukemia responding to imatinib may identify those at high risk of disease progression;Khorashad;J Clin Oncol,2008

4. Poor response to second-line kinase inhibitors in chronic myeloid leukemia patients with multiple low-level mutations, irrespective of their resistance profile;Parker;Blood,2012

5. Sensitive detection of BCR-ABL1 mutations in patients with chronic myeloid leukemia after imatinib resistance is predictive of outcome during subsequent therapy;Parker;J Clin Oncol,2011

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of a novel NGS based BCR::ABL1 kinase domain mutation detection assay in Indian cohort;Scientific Reports;2024-07-08

2. Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-02

3. Resistance mutations in CML and how we approach them;Hematology;2023-12-08

4. European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia;Leukemia;2023-10-04

5. BCR::ABL1 kinase domain mutation testing and clinical outcome in a nationwide chronic myeloid leukemia patient population;European Journal of Haematology;2023-09-20